| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | -0.0024 | 1 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | 0.00082 | 1 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00074 | 1 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.0009 | 1 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | -0.00067 | 1 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | -0.00061 | 1 |